TIMOTHY A. SPRINGER - 12 Aug 2024 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role: Director, 10%+ Owner
Signature: /s/ Matthew Bartholomae, Attorney-in-Fact for Timothy A. Springer
Issuer symbol: RNAC
Transactions as of: 12 Aug 2024
Transactions value $: $101,968
Form type: 4
Filing time: 14 Aug 2024, 16:43:58 UTC
Previous filing: 05 Jul 2024
Next filing: 20 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RNAC	Common Stock	Purchase	$102K	+8.02K	+229.49%	$12.72	11.5K	12 Aug 2024	By wife	F1
holding	RNAC	Common Stock						4.38M	12 Aug 2024	Direct
holding	RNAC	Common Stock						1.93M	12 Aug 2024	See Footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $12.48 to $13.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	Held by TAS Partners LLC. The reporting person is the managing member of TAS Partners LLC. The reporting person disclaims beneficial ownership of the securities held by TAS Partners LLC except to the extent of his pecuniary interest therein, if any.